TAHSEEN GILL: Open Payments
NPI 1275127748 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 73 payments from 14 companies in 2025. Trend: 2023 $1,013 · 2024 $1,320 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $268 |
| Corium, LLC | 9 | $256 |
| Noven Therapeutics, LLC | 8 | $152 |
| Janssen Pharmaceuticals, Inc | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Tris Pharma Inc | 3 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| Lundbeck LLC | 3 | $52 |
Products named: VRAYLAR, Azstarys, Xelstrym, REXULTI, SPRAVATO, AUSTEDO XR, CAPLYTA, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
